Abstract The SARS-CoV-2 Omicron BA. 1 variant emerged in late 2021 and is characterised
by multiple spike mutations across all spike domains. Here we show that Omicron BA. 1 has …

Abstract The SARS-CoV-2 B. 1.1. 529/Omicron variant was first characterized in South Africa
and was swiftly designated a variant of concern 1. Of great concern is its high number of …

A limitation of current SARS-CoV-2 vaccines is that they provide minimal protection against
infection with current Omicron subvariants,, although they still provide protection against …

The evolvement of coronavirus variants is socially unacceptable but understandable in a
world that has grown tired of playing defence against “severe acute respiratory syndrome …

On 24 November, a new detected variant B. 1.1. 529 of SARS-CoV-2 by South Africa was
reported to WHO. After only 2 days, this variant was designated as “variant of concern”(VOC) …

The Omicron variant rapidly became the dominant SARS‐CoV‐2 strain in South Africa and
elsewhere. This review explores whether this rise was due to an increased transmission of …

Summary The SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations that
contribute to escape from the neutralizing antibody responses, and reducing vaccine …

The SARS-CoV-2 Omicron (B. 1.1. 529) variant first emerged as the BA. 1 sub-lineage, with
extensive escape from neutralizing immunity elicited by previous infection with other …

Omicron, the novel, highly mutated SARS‐CoV‐2 Variant of Concern (belonging to the
Pango lineage B. 1.1. 529), was first collected on November 8, 2021, in Gauteng province of …

The rapid spread of the SARS-CoV-2 Omicron (B. 1.1. 529) variant, including in highly
vaccinated populations, has raised important questions about the efficacy of current …